Articles

1. VOLY: The Monetary Value of a Life-Year at the End of Patients’ Lives

   • Elizabeta Ribarić
   • Ismar Velić
   • Ana Bobinac

   Original Research Article 04 October 2023 Pages: 97 - 106

   

2. Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions

   • Rakhee Raghunandan
   • Kirsten Howard
   • Alison Hayes

   Original Research Article Open access 03 October 2023 Pages: 949 - 965

   

3. Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study

   • Emma McManus
   • Rachel Meacock
   • Matt Sutton

   Original Research Article Open access 03 October 2023 Pages: 891 - 903

4. Child–Parent Agreement in the Assessment of Health-Related Quality of Life Using the CHU9D and the PedsQL^TM

   • Diana Khanna
   • Jyoti Khadka
   • in Collaboration with the Quality of Life in Kids: Key Evidence to Strengthen Decisions in 6 Australia (QUOKKA) Project Team

   Original Research Article Open access 29 September 2023 Pages: 937 - 947

   

5. Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?

   • Howard Thom

   Correction Open access 27 September 2023 Pages: 967 - 967

6. Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices

   • Aniek Dane
   • Anne-Sophie Klein Gebbink
   • Carin A. Uyl-de Groot

   Original Research Article Open access 26 September 2023 Pages: 905 - 914

   

7. Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review

   • Sibo Liu
   • Daniel SW Tan
   • Ann-Marie Chacko

   Systematic Review 25 September 2023 Pages: 841 - 855

   

8. The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022

   • Michela Meregaglia
   • Francesco Malandrini
   • Oriana Ciani

   Original Research Article Open access 02 September 2023 Pages: 925 - 935

   

9. Is Using Sodium-Glucose Cotransporter-2 Inhibitors to Treat Adults with Chronic Heart Failure Cost-Effective? A Systematic Review of Cost-Effectiveness Studies

   • Yi Jing Tan
   • Siew Chin Ong
   • Ying Min Kan

   Systematic Review 30 August 2023 Pages: 857 - 875

   

10. Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia

    • Martin Vu
    • Koen Degeling
    • Maarten J. IJzerman

    Original Research Article Open access 22 August 2023 Pages: 107 - 122

    

11. Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040

    • Marta Ortega-Ortega
    • Paul Hanly
    • Linda Sharp

    Original Research Article Open access 08 August 2023 Pages: 877 - 889

12. The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates

    • Varsha Shukla
    • Rahul Arora

    Systematic Review 28 July 2023 Pages: 719 - 730

    

13. Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On

    • Paula K. Lorgelly
    • Daniel J. Exeter

    Commentary Open access 20 July 2023 Pages: 683 - 687

    

14. Values in Modelling: Video Series Development and Evaluation Survey

    • Stephanie Harvard
    • Adam Easterbrook
    • David Murphy

    Research Letter 05 July 2023 Pages: 813 - 820

15. Correction to: The False Economy of Seeking to Eliminate Delayed Transfers of Care: Some Lessons from Queueing Theory

    • Richard M. Wood
    • Alison L. Harper
    • Christos Vasilakis

    Correction Open access 03 July 2023 Pages: 821 - 821

16. Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government

    • Karel H. van der Pol
    • Mohamad Aljofan
    • Michael Spedding

    Current Opinion Open access 03 July 2023 Pages: 831 - 840

17. Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models

    • Ali Ahmed
    • Juman Abdulelah Dujaili
    • Nathorn Chaiyakunapruk

    Systematic Review Open access 30 June 2023 Pages: 731 - 750

    

18. A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?

    • Rajani Pokharel
    • Yi-Shu Lin
    • James F. O’Mahony

    Systematic Review Open access 28 June 2023 Pages: 701 - 717

    

19. Value for Money of CAR-T Cell Therapy for Patients with Diffuse Large B-cell Lymphoma in China: Evidence from a Cost-Effectiveness Analysis

    • Weijia Wu
    • Yuping Zhou
    • Hengjin Dong

    Original Research Article 25 June 2023 Pages: 773 - 783

    

20. Direct Medical Costs of COPD in the USA: An Analysis of the Medical Expenditure Panel Survey 2017–2018

    • Chintal H. Shah
    • Robert M. Reed
    • Zafar Zafari

    Original Research Article 03 June 2023 Pages: 915 - 924

    

21. What About Offering a Financial Incentive Directly to Clinical Units to Encourage the Use of Biosimilars? Results of a Two-Year National Experiment in France

    • Marion Tano
    • Pascal Paubel
    • Albane Degrassat-Théas

    Original Research Article 30 May 2023 Pages: 799 - 811

    

22. 10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?

    • Melanie Büssgen
    • Tom Stargardt

    Original Research Article Open access 30 May 2023 Pages: 751 - 759

    

23. myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology

    • Heather Davies
    • Mary Chappell
    • Judith Shore

    Review Article Open access 28 May 2023 Pages: 689 - 700

24. Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life

    • Caterina Alacevich
    • Inna Thalmann
    • Stavros Petrou

    Original Research Article 27 May 2023 Pages: 761 - 771

    

25. Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration

    • Anagha Killedar
    • Thomas Lung
    • Alison Hayes

    Original Research Article Open access 23 May 2023 Pages: 615 - 625

    

26. Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden

    • Jaesh Naik
    • Norma Beavers
    • Chrissy Lowry

    Original Research Article Open access 12 May 2023 Pages: 661 - 672

    

27. Preferences for Enhanced Primary Care Services Among Older Individuals and Primary Care Physicians

    • Semra Ozdemir
    • John Ansah
    • David Matchar

    Original Research Article 09 May 2023 Pages: 785 - 797

    

28. Public Preferences for Introducing a COVID-19 Certificate: A Discrete Choice Experiment in the Netherlands

    • J. Veldwijk
    • J. van Exel
    • N. Mouter

    Original Research Article Open access 08 May 2023 Pages: 603 - 614

    

29. Health technology assessment – an important opportunity to inform the use of medical devices in the paediatric population: an analysis of NICE Medical Technology Guidance

    • Sarah Greasley
    • Mark Campbell
    • James Wall

    Commentary 06 May 2023 Pages: 533 - 535

30. Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments

    • Joseph Kwon
    • Sarah Smith
    • Stavros Petrou

    Systematic Review Open access 03 May 2023 Pages: 559 - 584

    

31. Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System^® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections in Argentina

    • Alfredo Palacios
    • Federico Rodriguez-Cairoli
    • Ariel Bardach

    Original Research Article 16 April 2023 Pages: 637 - 650

    

32. Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment

    • Jennifer R. Donnan
    • Karissa Johnston
    • Lisa D. Bishop

    Original Research Article Open access 15 April 2023 Pages: 651 - 659

    

33. The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework

    • Laura Vallejo-Torres

    Practical Application Open access 12 April 2023 Pages: 373 - 384

    

34. A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany

    • Afschin Gandjour

    Original Research Article Open access 11 April 2023 Pages: 627 - 635

    

35. How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts

    • Matthew Franklin
    • Colin Angus
    • Guy Joos

    Practical Application Open access 11 April 2023 Pages: 547 - 558

    

36. Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends

    • Haode Wang
    • Donna L. Rowen
    • Litian Jiang

    Systematic Review Open access 30 March 2023 Pages: 405 - 418

    

37. Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults

    • Annette K. Regan
    • Pallavi Aytha Swathi
    • Ning Yan Gu

    Original Research Article Open access 25 March 2023 Pages: 523 - 532

    

38. Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review

    • Sean Docking
    • Lan Gao
    • Rachelle Buchbinder

    Systematic Review Open access 20 March 2023 Pages: 467 - 475

    

39. Medication Adherence and Healthcare Costs in Chronically Ill Patients Using German Claims Data

    • Johannes Wendl
    • Andreas Simon
    • Alexander Hapfelmeier

    Original Research Article Open access 18 March 2023 Pages: 477 - 487

    

40. Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand

    • Waranya Rattanavipapong
    • Chittawan Poonsiri
    • Yot Teerawattananon

    Original Research Article Open access 16 March 2023 Pages: 511 - 522

    

41. Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe

    • Christopher H. Henshall
    • Dávid Dankó
    • Nils Wilking

    Leading Article 10 March 2023 Pages: 537 - 546

    

42. Stakeholder Engagement in the Development of Public Health Economic Models: An Application to Modelling of Minimum Unit Pricing of Alcohol in South Africa

    • N. K. Gibbs
    • C. Angus
    • P. S. Meier

    Practical Application 09 March 2023 Pages: 395 - 403

    

43. Modelling Methods of Economic Evaluations of HIV Testing Strategies in Sub-Saharan Africa: A Systematic Review

    • Arthi Vasantharoopan
    • Victoria Simms
    • Hendramoorthy Maheswaran

    Systematic Review 28 February 2023 Pages: 585 - 601

    

44. An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology

    • Holly L. Cranmer
    • Gemma E. Shields
    • Ash Bullement

    Practical Application 27 February 2023 Pages: 385 - 394

    

45. Global Pull Incentives for Better Antibacterials: The UK Leads the Way

    • Kevin Outterson
    • John H. Rex

    Commentary Open access 11 February 2023 Pages: 361 - 364

46. The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review

    • Diogo L. L. Leao
    • Henricus-Paul Cremers
    • Wim Groot

    Systematic Review Open access 01 February 2023 Pages: 441 - 466

    

47. A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America

    • Carlos Rojas-Roque
    • Alfredo Palacios

    Systematic Review 31 January 2023 Pages: 419 - 440

    

48. The Impact of Suboxone’s Market Exclusivity on Cost of Opioid Use Disorder Treatment

    • Meghan McGee
    • Kellia Chiu
    • Abhimanyu Sud

    Original Research Article Open access 18 January 2023 Pages: 501 - 510

    

49. Can the UK ‘Netflix’ Payment Model Boost the Antibacterial Pipeline?

    • Colm Leonard
    • Nick Crabb
    • Mark Perkins

    Practical Application Open access 17 January 2023 Pages: 365 - 372

    

50. Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis

    • Yawen Jiang
    • Shan Jiang
    • Lei Si

    Original Research Article 10 January 2023 Pages: 489 - 499